MedPath

Treatment of Cutaneous Ulcers With a Novel Biological Dressing

Phase 1
Completed
Conditions
Venous Ulcers
Registration Number
NCT00207818
Lead Sponsor
CHU de Quebec-Universite Laval
Brief Summary

The aim of the study is to evaluate the effect of a biological dressing on the healing process of venous ulcers. The dressing is a reconstructed skin substitute made with the patients own cells.

Detailed Description

The hypothesis of this trial is that the cutaneous model SASS, a dermal epidermal skin substitute, created by the LOEX could be as high-performant, or even better, than the one's already existent in North America for the wound care. We anticipate showing on 6 patients that ulcer that did not close with conventional treatment, will heal or at least improve with this treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
6
Inclusion Criteria
  1. Men or women from 18 to 85 years old
  2. Have a venous ulcer or a mixed ulcer
Exclusion Criteria

Diabetes Mental deficiency Hepatitis holder (A-B-C) HIV positive Pregnancy or lactation Corticosteroids therapy Radiotherapy Chemotherapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
wound closure
Secondary Outcome Measures
NameTimeMethod
% of healing at 6 months of treatment

Trial Locations

Locations (1)

Centre hospitalier affilie universitaire de Quebec

🇨🇦

Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath